Drugs / L-oxiracetam
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT04205565 Comparator | Sep 2019 → Aug 2024 | brain injury | Nanjing Yoko Biomedical Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | L-oxiracetam | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04205565 ↗ |
| Route | Intravenous | “L-oxiracetam injection, 4 vials, once a day, IV.” NCT04205565 ↗ |